Browse by region

World Map Middle East Africa South Asia Asia/Pacific Europe South America North America

Regulations for Synthetic Biology Need to Address Risks and Rewards

How much should synthetic biology – the design and construction of new biological parts, devices and systems, and the redesign of existing, natural biological systems for useful purposes – be regulated? And by whom?

Biodefense System Overhaul Was Necessary, HHS Secretary Says

WASHINGTON — A planned $1.9 billion revamp of the nation’s medical countermeasure enterprise was overdue as government scientists were using decades old technology to confront new and emerging biological threats, a senior Obama administration official said here last week (see GSN, Sept. 24). (Sep. 27) – Workers on a vaccine production  Read More »

New Biodefense Office, Existing Agency Could Cover Same Ground

An Obama administration plan to establish a “strategic investment firm” for promoting development of biological-weapon and other disease countermeasures could raise questions over division of responsibilities with a Health and Human Services Department agency engaged in related work, Congressional Quarterly reported Wednesday (see GSN, Aug. 20).Unlike the existing Biomedical Advanced Research  Read More »

Work begins on the new U.S. premier BioLab

DHS has released $40 million to allow work to begin on the U.S. new National Bio and Agro-Defense Facility, located on the campus of Kansas State University; the lab will replace the aging lab on Plum Island as the premier research center to combat the threat of naturally occurring animal diseases  Read More »

New $186.6 million contract shows anthrax threat real

In an indication that the threat of an anthrax outbreak as a result of bioterrorism remains a major priority for the Obama administration, Maryland-based Emergent BioSolutions received a contract valued at up to $186.6 million from the Department of Health and Human Services to develop a recombinant protective antigen anthrax vaccine,  Read More »